articleNatureOct 26, 2003Closed access

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

DLDaniel LamarrePCPaul C. AndersonMDMurray D. BaileyPLPierre L. BeaulieuGTGordon T. Bolger

Boehringer Ingelheim (Egypt) · Boehringer Ingelheim (Canada) · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

913
total citations
FWCI
34.16
Percentile
100%
References
30
Citations per year

Authors

28

Topics & keywords

Topics
Keywords
  • NS3
  • Hepatitis C virus
  • Virology
  • Protease inhibitor (pharmacology)
  • Protease
  • Hepatitis C
  • Medicine
  • Ribavirin
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.